A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
主要作者: | Islam, Nahidul |
---|---|
其他作者: | Talukder, Mesbah |
格式: | Thesis |
語言: | English |
出版: |
Brac University
2023
|
主題: | |
在線閱讀: | http://hdl.handle.net/10361/22025 |
相似書籍
-
TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
由: Afroza, Halima
出版: (2024) -
Biologics and Biosimilars as Treatment Options for Psoriasis
由: Moya, Amena Khatun
出版: (2023) -
Association of GLP-1 receptor agonists and risk of pancreatitis: a pharmacovigilance study based on FAERS database
由: Bishakha, Adwiza Chakraborty
出版: (2024) -
Safety and efficacy of dutasteride for male Androgenetic Alopecia
由: Islam, S.M. Zahidul
出版: (2024) -
Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
由: Khandker, Tahia Anjum
出版: (2024)